Envue Medical signs exclusive UroShield distribution deal with £2.1 million minimum purchases in UK, Ireland

• Envue Medical signed an exclusive UroShield distribution deal with Peak Medical for the UK and Republic of Ireland through Dec. 31, 2029.
• Agreement includes minimum purchase commitments of about $2.6 million over the initial term.
• Annual minimum volumes rise from 650 units in 2026 to 35,000 units in 2029.
• Contract includes an option to renew for an additional three-year period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envue Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608180830PRIMZONEFULLFEED9811951) on August 18, 2026, and is solely responsible for the information contained therein.